Ethylidenedioxyamphetamine
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 1-(2-methylbenzo[d][1,3]dioxol-5-yl)propan-2-amine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | None |
| PubChem | CID 130542 |
| Chemical data | |
| Formula | C11H15NO2 |
| Mol. mass | 193.242 g/mol |
| SMILES | eMolecules & PubChem |
 (what is this?) (verify) |
Ethylidenedioxyamphetamine (EDA) is a substituted derivative of methylenedioxyamphetamine (MDA), which was developed by David Nichols and coworkers, in the course of research to determine the bulk tolerance around the benzodioxole portion of the MDA molecule. EDA was found to produce similar effects to MDA in animals but with less than half the potency, while the isopropylidinedioxy derivative (IDA) did not substitute for MDA and instead had sedative and convulsant effects. This shows limited bulk tolerance at this position and (as with 2C-G-5) makes it likely the activity of EDA will reside primarily in one enantiomer, although only the racemic mix has been studied as yet.[1][2][3]
[edit] See also
[edit] References
- ^ Nichols DE, Kostuba LJ (October 1979). "Steric effects of substituents on phenethylamine hallucinogens. 3,4-(Methylenedioxy)amphetamine analogues alkylated on the dioxole ring". Journal of Medicinal Chemistry 22 (10): 1264–7. doi:10.1021/jm00196a022. PMID 513074.
- ^ Nichols DE, Oberlender R, Burris K, Hoffman AJ, Johnson MP (November 1989). "Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA) analogues". Pharmacology, Biochemistry, and Behavior 34 (3): 571–6. doi:10.1016/0091-3057(89)90560-1. PMID 2623014.
- ^ Trachsel D, Hadorn M, Baumberger F (March 2006). "Synthesis of fluoro analogues of 3,4-(methylenedioxy)amphetamine (MDA) and its derivatives". Chemistry & Biodiversity 3 (3): 326–36. doi:10.1002/cbdv.200690035. PMID 17193269.
